| 1281/1664 | US=104 / Câncer Marsden DD, Hacker NF. Breast cancer: vulva cancer. In: Gospodarowicz MK, Sullivan BO, Sobin LH. Prognostic factors in cancer. New Jersey: John Wiley & Sons, 2006. p. 215-8. (International Union Against Cancer) ISBN 978-0-470-03801-2. |
| 1282/1664 | US=104 / Câncer Hauspy J, Harley I, Fyles AW. Breast cancer: uterine cervix cancer. In: Gospodarowicz MK, Sullivan BO, Sobin LH. Prognostic factors in cancer. New Jersey: John Wiley & Sons, 2006. p. 219-22. (International Union Against Cancer) ISBN 978-0-470-03801-2. |
| 1283/1664 | US=104 / Câncer Pecorelli S, Pasinetti B, Tisi G, Zigliani L, Odicino F. Breast cancer: ovarian and fallopian tube cancer. In: Gospodarowicz MK, Sullivan BO, Sobin LH. Prognostic factors in cancer. New Jersey: John Wiley & Sons, 2006. p. 223-8. (International Union Against Cancer) ISBN 978-0-470-03801-2. CANCER DE MAMA; CANCER DE OVARIO; CANCER DE TROMPAS DE FALOPIO |
| 1284/1664 | US=104 / Câncer Herrera FG, Milosevic MF. Breast cancer: endometrial cancer. In: Gospodarowicz MK, Sullivan BO, Sobin LH. Prognostic factors in cancer. New Jersey: John Wiley & Sons, 2006. p. 229-32. (International Union Against Cancer) ISBN 978-0-470-03801-2. |
| 1285/1664 | US=104 / Câncer Ngan HYS, Chan KKL, Tam KF. Breast cancer: gestational trophoblastic disease. In: Gospodarowicz MK, Sullivan BO, Sobin LH. Prognostic factors in cancer. New Jersey: John Wiley & Sons, 2006. p. 233-5. (International Union Against Cancer) ISBN 978-0-470-03801-2. |
| 1286/1664 | US=11 / Radioterapia Kelley JR, Cuttino LW, Vicini FA, Arthur DW. Breast brachytherapy. In: Devlin PM. Brachytherapy: applications and techniques. Philadelphia: J.B. Lippincott, 2006. p. 115-35. ISBN 978-0-7817-6277-9. |
| 1287/1664 | US=17 / Biol/Mol Kiaris H. Specific topics: hormones and cancer. In: ___. Understanding carcinogenesis: an introduction to the molecular basis of cancer. Weinheim: Wiley-VCH, 2006. p. 113-22. ISBN 978-3-527-31486-7. HORMONIOS; CANCER; ANDROGENOS; CANCER DE PROSTATA; ESTEROIDES SEXUAIS; CANCER DE MAMA; CHRH; CARCINOGENESE |
| 1288/1664 | US=17 / Biol/Mol Kiaris H. Specific topics: carcinogenesis in vivo: animal models and basic approaches to generate genetically modified animals. In: ___. Understanding carcinogenesis: an introduction to the molecular basis of cancer. Weinheim: Wiley-VCH, 2006. p. 136-59. ISBN 978-3-527-31486-7. CARCINOGENESE IN VIVO; MODELOS ANIMAIS; CARCINOGENESE EM RATOS; CAMUNDONGOS TRANSGENICOS; ESTUDAR PROMOTORES; MUTACOES ESPECIFICAS; TUMORES PANCREATICOS; CANCER DE MAMA; NEUROFIBROMATOSE TIPO I; NEUROFIBROMATOSE TIPO II; TUMORES DO INTESTINO; MALIGNIDADES HEMATOPOIETICAS; MELANOMA; CAMUNDONGOS DEFICIENTES P53; INSTABILIDADE GENOMICA; INSTABILIDADE DE MICROSSATELITES; INSTABILIDADE CROMOSSOMICA; TELOMEROS; RECOMBINACAO MITOTICA; RECOMBINACAO ESPONTANEA; INFECCOES VIRAIS RESTRITOS |
| 1289/1664 | US=2 / Mama Simon RM. General topics: guidelines for the design of clinical studies for the development and validation of therapeutically relevant biomarkers and biomarker-based classification systems. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 1-15. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. CANCER DE MAMA; BIOMARCADORES; MICROARRAYS; SISTEMA DE CLASSIFICACAO; ENSAIOS CLINICOS |
| 1290/1664 | US=2 / Mama Sweep FCGJ, Thomas CMG, Schmitt M. General topics: analytical aspects of biomarker immunoassays in cancer research. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 17-30. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. CANCER DE MAMA; BIOMARCADORES; IMUNOENSAIOS; MARCADORES TUMORAIS |
| 1291/1664 | US=2 / Mama Kim C, Paik S. General topics: tissue microarrays: state of the art, pitfalls, and promises. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 31-44. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. CANCER DE MAMA; BIOMARCADORES; TISSUE MICROARRAYS; ENSAIOS CLINICOS MULTICENTRICOS; TISSUE ARRAY |
| 1292/1664 | US=2 / Mama De Bortoli M, Biglia N. Assays for gene expression and post-translational protein abnormalities: gene expression profiling with DNA microarrays: revolutionary tools to help diagnosis, prognosis, treatment guidance, and drug discovery. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 47-61. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. CANCER DE MAMA; ENSAIOS DA EXPRESSAO DO GENE; ANORMALIDADES POS-TRADUCIONAIS; PERFIL DE EXPRESSAO GENICA; MICROARRANJOS DE DNA |
| 1293/1664 | US=2 / Mama Kim C, Song Y, Paik S. Assays for DNA abnormalities: assays for gene amplification. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 65-77. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. CANCER DE MAMA; ANOMALIAS DO DNA; ENSAIOS PARA AMPLIFICACAO DO GENE; TRASTUZUMABE; TESTE HER-2 |
| 1294/1664 | US=2 / Mama Duffy MJ. Tissue predictive biomakers: urokinase-type plasminogen activator and PAI-1. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 111-28. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; UROQUINASE; PLASMINOGENIO; PAI-1; CANCER; MARCADORES TUMORAIS; CANCER DE MAMA |
| 1295/1664 | US=2 / Mama Duffy MJ. Tissue predictive biomakers: predictive value of c-erb-B2 for endocrine therapy and chemotherapy in breast cancer. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 129-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; VALOR PREDITIVO DE C-ERB-B2; HORMONIOTERAPIA; QUIMIOTERAPIA; CANCER DE MAMA; TRASTUZUMABE |
| 1296/1664 | US=2 / Mama Mass R. Tissue predictive biomakers: erb-B2 as a therapeutic target. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 159-75. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; ERB-B2; ALVO TERAPEUTICO; CANCER DE MAMA; HER2; TRASTUZUMABE; ANTICORPOS MONOCLONAIS |
| 1297/1664 | US=2 / Mama Ciardiello F, Troiani T, Tortora G. Tissue predictive biomakers: the epidermal growth factor receptor pathway as a selective molecular-targeted treatment in human breast cancer. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 177-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCAORES PREDITIVOS; FATOR DE CRESCIMENTO EPIDERMICO; VIA RECEPTOR; CANCER DE MAMA; EGF; EGFR |
| 1298/1664 | US=2 / Mama Braun S, Seeber J, Marth C. Predictive biomarkers in body fluids: occult metastatic cells in breast cancer patients. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 213-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; CELULAS METASTATICAS; CANCER DE MAMA; PROGNOSTICO |
| 1299/1664 | US=2 / Mama Lipton A, Demmers L, Leitzel K, Ali SM, Neumann R, Price CP, Carney WP. Predictive biomarkers in body fluids: circulating HER2/neu: clinical utility. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 235-65. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; CIRCULACAO HER2/NEU; ONCOPROTEINA; CANCER DE MAMA |
| 1300/1664 | US=2 / Mama Sarmiento R, Franceschini R, Meo S, Gion M, Longo R, Gaspirini G. Predictive biomarkers in body fluids: circulating vascular endothelial growth factor. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 267-92. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; CIRCULACAO; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; CANCER DE MAMA; ANGIOGENESE; TERAPIA; PROGNOSTICO |